Stratec SE (ETR:SBS - Get Free Report) fell 0.2% on Friday . The company traded as low as €29.10 ($30.00) and last traded at €29.75 ($30.67). 10,049 shares were traded during mid-day trading, an increase of 61% from the average session volume of 6,253 shares. The stock had previously closed at €29.80 ($30.72).
Stratec Price Performance
The company has a debt-to-equity ratio of 65.99, a current ratio of 2.47 and a quick ratio of 1.65. The firm has a market capitalization of $361.76 million, a PE ratio of 25.00, a P/E/G ratio of 10.43 and a beta of 0.16. The company has a 50-day moving average price of €30.93 and a 200-day moving average price of €38.59.
About Stratec
(
Get Free Report)
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications.
Featured Stories
Before you consider Stratec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stratec wasn't on the list.
While Stratec currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
